On the Corner of Models and Cure: Gene Editing in Cystic Fibrosis
Cystic fibrosis (CF) is a severe genetic disease for which curative treatment is still lacking. Next generation biotechnologies and more efficient cell-based and in vivo disease models are accelerating the development of novel therapies for CF. Gene editing tools, like CRISPR-based systems, can be u...
Main Authors: | Marjolein Ensinck, Angélique Mottais, Claire Detry, Teresinha Leal, Marianne S. Carlon |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-04-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.662110/full |
Similar Items
-
Cystic Fibrosis - a very common genetic disease among the population - a general review
by: Julia Rutkowska, et al.
Published: (2023-06-01) -
One Size Does Not Fit All: The Past, Present and Future of Cystic Fibrosis Causal Therapies
by: Marjolein M. Ensinck, et al.
Published: (2022-06-01) -
Early developmental phenotypes in the cystic fibrosis sheep model
by: Arnaud J. Van Wettere, et al.
Published: (2023-01-01) -
Animal Models in the Pathophysiology of Cystic Fibrosis
by: Anna Semaniakou, et al.
Published: (2019-01-01) -
Cystic fibrosis mutation spectrum in north macedonia: A step toward personalized therapy
by: Terzic M, et al.
Published: (2019-08-01)